In vitro activity of telavancin against Staphylococcus aureus causing pneumonia or skin and skin structure infections with concomitant bloodstream infections in United States hospitals (2012-2016)

被引：0
|
作者：
Duncan, Leonard R. [1 ]
Flamm, Robert K. [1 ]
Sader, Helio S. [1 ]
Mendes, Rodrigo E. [1 ]
机构：
[1] JMI Labs, North Liberty, IA 52317 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2019年 / 93卷 / 02期
关键词：
Telavancin; Staphylococcus aureus; Bloodstream infection; SSSI; Pneumonia; BACTEREMIA; VANCOMYCIN; EPIDEMIOLOGY; MANAGEMENT; FOCUS;
D O I：
10.1016/j.diagmicrobio.2018.09.011
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Pneumonia and skin and skin structure infections (SSSIs) caused by S. aureus can lead to serious bloodstream infections (BSIs). This study reports on potent telavancin in vitro activity (MIC90, 0.06 mu g/mL; 100% susceptible) against 674 US S. aureus causing pneumonia or SSSI with associated BSI in hospitalized patients during 2012-2016. (C) 2018 The Authors. Published by Elsevier Inc.
引用
收藏
页码：167 / 170
页数：4
相关论文
共 39 条
  • [31] Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children
    Frei, Christopher R.
    Makos, Brittany R.
    Daniels, Kelly R.
    Oramasionwu, Christine U.
    JOURNAL OF PEDIATRIC SURGERY, 2010, 45 (10) : 1967 - 1974
  • [32] Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020
    Duncan, Leonard R.
    Hamed, Kamal A.
    Smart, Jennifer I.
    Pfaller, Michael A.
    Flamm, Robert K.
    Mendes, Rodrigo E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 103 (03)
  • [33] Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012)
    Sader, Helio S.
    Farrell, David J.
    Flamm, Robert K.
    Jones, Ronald N.
    JOURNAL OF INFECTION, 2014, 69 (03) : 266 - 277
  • [34] Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019)
    Carvalhaes, Cecilia G.
    Sader, Helio S.
    Streit, Jennifer M.
    Castanheira, Mariana
    Mendes, Rodrigo E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (02)
  • [35] Molecular Epidemiologic and Geo-Spatial Characterization of Staphylococcus aureus Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City
    Immergluck, Lilly Cheng
    Lin, Xiting
    Geng, Ruijin
    Edelson, Mike
    Ali, Fatima
    Li, Chaohua
    Lin, T. J.
    Khalida, Chamanara
    Piper-Jenks, Nancy
    de la Gandara, Maria Pardos
    de Lencastre, Herminia
    Tomasz, Alexander
    Evering, Teresa H.
    Kost, Rhonda G.
    Vaughan, Roger
    Tobin, Jonathan N.
    ANTIBIOTICS-BASEL, 2023, 12 (10):
  • [36] Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from United States hospitals in 2017-2019
    Sader, Helio S.
    Streit, Jennifer M.
    Mendes, Rodrigo E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (01)
  • [37] In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012-2014
    Karlowsky, James A.
    Biedenbach, Douglas J.
    Bouchillon, Samuel K.
    Hackel, Meredith
    Iaconis, Joseph P.
    Sahm, Daniel F.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 86 (02) : 194 - 199
  • [38] In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme
    Karlowsky, James A.
    Biedenbach, Douglas J.
    Bouchillon, Samuel K.
    Iaconis, Joseph P.
    Reiszner, Edina
    Sahm, Daniel F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) : 162 - 169
  • [39] Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa collected from patients with bloodstream infections isolated in United States hospitals (2013-2015) as part of the Program to Assess Ceftolozane-Tazobactam Susceptibility (PACTS) surveillance program
    Shortridge, Dee
    Pfaller, Michael A.
    Castanheira, Mariana
    Flamm, Robert K.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 92 (02) : 158 - 163
1234